The National Drug Abuse Treatment Clinical Trials Network (UG1 Clinical Trial Required) | RFA DA 20 024

Opportunity Information: Apply for RFA DA 20 024

The National Drug Abuse Treatment Clinical Trials Network (CTN) funding opportunity, titled "The National Drug Abuse Treatment Clinical Trials Network (UG1 Clinical Trial Required)" (Funding Opportunity Number RFA-DA-20-024), is a discretionary grant offered by the U.S. Department of Health and Human Services through the National Institutes of Health, specifically the National Institute on Drug Abuse (NIDA). It uses a cooperative agreement mechanism (UG1), which generally means awardees do not work in isolation; instead, they operate in an active partnership with NIDA and the broader CTN structure. The core purpose is to bring clinical investigators into the CTN so they can help strengthen and expand the network's ability to rapidly design and conduct rigorous clinical trials that respond to urgent and evolving public health needs related to substance use.

At a program level, the FOA focuses on developing and testing interventions across the full spectrum of substance use problems. That includes, in practical terms, evaluating prevention, treatment, and recovery approaches in real-world clinical settings, with an emphasis on producing results that can be adopted by healthcare systems and community-based providers. The CTN model is built around collaboration among NIDA, clinical research investigators, healthcare providers, and healthcare institutions, so the funded work is meant to be clinically grounded and implementation-relevant rather than purely academic. Because the announcement specifies "Clinical Trial Required," applications are expected to include clinical trial activity aligned with the CTN mission and infrastructure, reinforcing the network's capacity to generate evidence that can influence practice and policy.

Eligibility is intentionally broad to encourage participation from many kinds of organizations that can contribute to clinical research and service delivery. Eligible applicants include state, county, city, township, and special district governments; independent school districts; public and state-controlled institutions of higher education; private institutions of higher education; federally recognized Native American tribal governments as well as other tribal organizations; public housing authorities and Indian housing authorities; nonprofit organizations with or without 501(c)(3) status (excluding higher education institutions under those nonprofit categories); for-profit organizations (other than small businesses); small businesses; and other entities as described in the FOA's additional eligibility language. This wide eligibility reflects the reality that substance use treatment and related services are delivered in many settings, and NIDA is seeking a network that can recruit diverse sites and populations and translate findings into routine care.

In terms of funding details, the opportunity is associated with CFDA number 93.279, had a creation date of September 4, 2019, and listed an original closing date of November 15, 2019. The stated award ceiling is $500,000, and NIDA anticipated making around 13 awards. Taken together, those figures suggest a competitive, multi-award effort intended to support a set of investigators and organizations that, collectively, can help the CTN maintain national readiness to launch studies quickly, coordinate across multiple sites, and address emerging substance use challenges with evidence-based clinical trial methods.

• The Department of Health and Human Services, National Institutes of Health in the education, health sector is offering a public funding opportunity titled "The National Drug Abuse Treatment Clinical Trials Network (UG1 Clinical Trial Required)" and is now available to receive applicants.
• Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.279.
• This funding opportunity was created on Sep 04, 2019.
• Applicants must submit their applications by Nov 15, 2019. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
• Each selected applicant is eligible to receive up to $500,000.00 in funding.
• The number of recipients for this funding is limited to 13 candidate(s).
• Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For profit organizations other than small businesses, Small businesses, Others (see text field entitled Additional Information on Eligibility for clarification).

Apply for RFA DA 20 024

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal: